Creating Microbiome Immunotherapeutics

Quorum Innovations is a biopharmaceutical company focused on discovering and developing human microbiome therapeutics. The Company's multiple therapeutic platforms establish Quorum Innovations at the forefront of this exciting scientific frontier.

Learn More

An Area of Transformational Medicine

The human microbiome, consisting of trillions of microbes, is a human-microbial superorganism. The relationship between the human host and its microbial collective is so vital that the microbiome can be considered another functioning body organ, and is increasingly accepted as having a pivotal role in human health and disease.

Learn More

Clinically-Driven Drug Discovery

We target clinical entities that are being re-interpreted as dysbiotic states. Our lead product is for atopic dermatitis, the first result of a discovery platform that addresses chronic inflammation and diseases of tissue barrier deficiency.

Learn More

MiNE™ discovery platform & Probiomic Therapeutics

MiNE™ technology focuses discovery effort on high therapeutic yield with target-organ-relevance. These Probiomic™ therapeutics effect a shift in states of dysbiosis to states of eubiosis, thereby promoting normal functioning of the target organ.

Learn More

Probiomic™ Therapeutics

Our lead candidate is for atopic dermatitis. Beyond AD, we have identified compounds for the treatment of other conditions characterized by chronic inflammation, loss of filaggrin and tissue barrier deficiency. These include allergic rhinitis, dry eye syndrome and eosinophilic esophagitis.


Learn More

The Microbiome as the Future of Medicine:

We are discovering that the human microbiome is as fundamental to our human health as any other organ system. Research suggests the importance of the microbiome in areas of human health such as heart disease, the development of our immune system, skin health, autoimmune diseases, metabolic diseases and even cognitive neuropsychological behaviors. These microbes work in our human bodies like a lock and key, providing the human host with energy, vitamins and metabolites that regulate inflammation and send signals to our brains. Not only is our understanding of 'what is human’ changing as we better understand our microbial counterparts, but it is also redefining how we think about diseases and how we treat our health.

Read More

Quorum’s mission is to become the global leader in microbiome therapeutics.

Recent News